Privacy Policy
Signals Blog

Contributors

Categories

David Kent

Dr. David Kent is a Principal Investigator at the York Biomedical Research Institute (https://www.york.ac.uk/biology/research/infection-immunity/david-kent/). His laboratory's research focuses on the fundamental biology of blood stem cells and how changes in their regulation lead to cancers. David has a long history of public engagement and outreach including the creation of The Black Hole (https://www.universityaffairs.ca/opinion/the-black-hole/) in 2009. He has been writing for Signals since 2010.

Posts by: David


Political furor drives government funding for clinical trial – who should fund stem cell therapy trials?

Author: David Kent, 05/28/13

. A few weeks ago, Italian private company Stamina came under considerable pressure regarding their controversial use of mesenchymal stem cells in patients. The Italian government, it seems, had authorized an unproven stem cell therapy for use in patients. The International Society for Stem Cell Research issued a statement of concern and numerous leading stem cell […]

The importance of unequal division in stem cells

Author: David Kent, 04/30/13

. Stem cells must strike a balance between different types of divisional outcomes in order to provide the correct numbers and types of cells for the lifetime of an organism. At each cell division, a stem cell either makes two replicates of itself to expand the population (a self-renewal division), makes two highly proliferating cells […]

Managing energy during hibernation: Stem cell metabolome profiling

Author: David Kent, 02/08/13

Previous posts from Angela and Michelle will have alerted readers to the importance of where a stem cell resides in the body. The stem cell niche is a complicated environment and one of the most challenging things for blood stem cell biologists to decipher is how “dormant” stem cells manage their energy in such an […]

Pleasantly surprised at World Stem Cells congress

Author: David Kent, 05/24/12

As a basic researcher in stem cell biology, one of my biggest fears is moving too quickly with cell therapies that involve primitive, still largely mysterious, cell populations. At the World Stem Cells & Regenerative Medicine Congress meeting this week, I felt much better about the direction that regenerative medicine is headed. It has been […]

Strategies to boost regenerative medicine: Growing an extra layer of skin

Author: David Kent, 05/22/12

You might expect this article to be about creating skin grafts for burn victims or something of that ilk. Instead though, it concerns the complicated process of taking a scientific discovery in regenerative medicine and bringing that discovery through clinical trials or commercialization to help people. If you imagine the middle of an onion as […]